English | Español
Amanda Rupp | Jun 5, 2016

AstraZeneca completes U.S. licensing agreement for Zurampic
Amanda Rupp | Jun 4, 2016

Prevention crucial to ending racial disparity gap for stroke patients
Amanda Rupp | Jun 3, 2016

Ocaliva receives FDA approval for rare, chronic liver disease
Amanda Rupp | Jun 3, 2016

AAFP members demonstrate increased interest
Amanda Rupp | Jun 3, 2016

Purdue Pharma forms patent agreement with Acura, Egalet
Amanda Rupp | Jun 3, 2016

BioMarin withdraws Kyndrisa's marketing authorization for Europe
Vimbai Chikomo | Jun 3, 2016

Coventry proposes 23 percent health insurance premium hike in Iowa
Amanda Rupp | Jun 2, 2016

Imbruvica gains approval for treating chronic lymphocytic leukemia

Trending
+ Pharmaceuticals
Patient Daily | Jun 30, 2025

PhRMA public affairs senior director on 340B program: 'PBMs took $140 billion in rebates and fees, driving up American medicine costs'
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

PhRMA chief public affairs officer on 340B drug pricing: ‘Lowering drug prices for U.S. patients starts by reining in middlemen’
+ Pharmaceuticals
Patient Daily | Jun 25, 2025

Neurosurgeon at the University of California: ‘340B is being exploited for profit, not patient care’
+ Pharmaceuticals
Patient Daily | Jul 1, 2025

American Lung Association launches campaign for World Bronchiectasis Day